Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.95    -0.25 (-7.81%)
Bid:
2.95
Ask:
3.11
Spread: 0.16 (5.424%)
Market Cap: £5.38m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Receipt of Final Litigation Proceeds

24 Jan 2024 07:00

RNS Number : 6851A
Nanoco Group PLC
24 January 2024
 

FOR IMMEDIATE RELEASE 24 January 2024

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (596/2014/EU) AS THE SAME HAS BEEN RETAINED IN UK LAW AS AMENDED BY THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR").

Nanoco Group plc

("Nanoco", the "Group", or the "Company")

 

Receipt of Final Litigation Proceeds

Proposals for Return of Capital to follow

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials emanating from its technology platform, today announces that it has received the second tranche of litigation proceeds from Samsung after settling last year on a no fault basis for the alleged infringement of the Group's IP.

The Group has received a net sum of $71.75m, being $75.0m less the expected Korean withholding tax, which amounted to $3.25m. The Korean withholding tax is available to offset Nanoco's future profits in the UK.

The Group previously announced the hedging of this tranche of proceeds at a rate of $1.22 / £1.00. The funds will be converted at this rate and generate a sterling receipt of £58.8m. This represents a gain of £2.1m compared to the current exchange rate for USD.

The Group is finalising its proposals for the amount and structure of the return of capital which can now go ahead following this receipt of the second tranche of litigation proceeds. The Group expects to update shareholders shortly on the final proposals which will be in line with the previously announced commitment to return between £33.0m and £40.0m to shareholders.

As previously communicated, the remaining proceeds will be invested in R&D and commercial activities to expand our range of high-performing materials, developing new materials with enhanced performance, as well as expanding our reach, a proactive IP licensing programme, payment of debt obligations, and to provide working capital through to the self-financing position that is expected during 2025.

Brian Tenner, Nanoco's CEO, commented:

"With receipt of these proceeds we can now finalise our plans for the significant return of capital to shareholders. The proceeds will also ensure that our commercial business is properly funded to take advantage of the growing commercial traction and development opportunities for our innovative platform technology."

- Ends -

 

The person responsible for arranging for the release of this announcement on behalf of Nanoco is Liam Gray, Company Secretary.

MAR

The information contained within this announcement is considered by the Company to contain inside information for the purposes of UK MAR. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

 

For further information, please contact:

Nanoco Group plc:

Brian Tenner, CEO ? +44 (0)1928 761 404

Liam Gray, CFO & Company Secretary

 

Cavendish Capital Markets Limited (Financial Adviser & Joint Corporate Broker):

Ed Frisby / George Lawson (Corporate Finance) +44 (0) 20 7220 0500

Tim Redfern / Charlie Combe (Corporate Broking)

Jasper Berry (Sales)

 

Turner Pope Investments (Joint Corporate Broker):

Andrew Thacker ? +44 (0) 20 3657 0050

James Pope

 

Powerscourt ? +44 (0)7970 246 725

Elly Williamson

Ollie Simmonds

Nanoco@powerscourt-group.com

 

FORWARD LOOKING STATEMENTS

This announcement (including information incorporated by reference in this announcement) and other information published by Nanoco may contain statements about Nanoco that are or may be deemed to be forward looking statements. Such statements are prospective in nature. All statements other than historical statements of facts may be forward looking statements. Without limitation, statements containing the words "targets", "plans", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "estimates", "projects" or "considers" or other similar words may be forward looking statements.

 

Forward looking statements inherently contain risks and uncertainties as they relate to events or circumstances in the future. Important factors such as business or economic cycles, the terms and conditions of Nanoco's financing arrangements, tax rates, or increased competition may cause Nanoco's actual financial results, performance or achievements to differ materially from any forward looking statements. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward looking statements, which speak only as of the date hereof. Nanoco disclaims any obligation to update any forward looking or other statements contained herein, except as required by applicable law.

 

About Nanoco Group plc

 

Nanoco (LSE: NANO) is a nano-material production and licensing company, specialising in the production of its patented cadmium free quantum dots (CFQD®) and other patented nano-materials for use in the electronics industries.

Founded in 2001 and headquartered in Runcorn, UK, Nanoco continues to build out a world-class, patent-protected IP portfolio alongside the scaling of the production for commercial orders.

Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Sensor, Electronics and Display markets. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of display applications. Nanoco's HEATWAVE? quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectrum, rendering them useful for applications including cameras and image sensors.

Nanoco is listed on the Main Market of the London Stock Exchange, holds the LSE's Green Economy Mark, and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRQKNBKDBKBADB
Date   Source Headline
22nd Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 20247:00 amRNSConclusions of Strategic Review
1st Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 202410:51 amRNSHolding(s) in Company
24th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20241:08 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
2nd Sep 20241:34 pmRNSHolding(s) in Company
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Aug 20247:00 amRNSCommercial Update
29th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20247:21 amRNSTransaction in Own Shares and Total Voting Rights
5th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Jul 20249:16 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20247:00 amRNSBoard and Management Change
25th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Jul 20242:14 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.